<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-114207</identifier>
<setSpec>1132-0095</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">No disponible</dc:title>
<dc:description xml:lang="en">Although already described more than one hundred years ago, Intra-abdominal hypertension (IAH) has recently raised a renewed interest, allowing a reduction in morbi-mortality. Normal intra-abdominal pressures may vary from less than 5 mmHg in normal conditions to 9 to 14 mmHg in different situations (obesity, pregnancy, critically ill patients).Definitions: Intra-abdominal hypertension is defined as an intra-abdominal pressure ?  12 mmHg in two different measurements separated at least by 6 hours. The term Abdominal Compartment Syndrome is defined as a value of intra-abdominal pressure ? 20 mmHg measured three times during 6 hours and associated to organ failure. There are many risk factors associated with this syndrome, above all intensive fluid resuscitation. This compartment syndrome may affect almost all body organs, by means of direct compression or indirectly for the inadequate tissue perfusion. Diagnosis: Intra-bladder pressure allows to estimate intra-abdominal pressure with minimal complications, thus it represents the chosen path of measurement. Intra-gastric measurements are used only in selected situations (neurogenic bladder, bladder trauma, etc.). Treatment: The pillars of IAH treatment should be: improving the compliance of the abdominal wall, evacuation of the space-occupying lesions, diminishing the intraluminal content, optimization of the tisular perfusion. In animal models new specific drugs have been used, such as melatonin and octreotide, with good results. Studies on humans are being carried on. Surgical decompression via laparotomy is indicated when medical treatments have failed or when patient&#146;s condition are critical. The abdominal wall can be kept open until patient&#146;s condition are improved. The open abdomen must be protected with a temporary surgical closure, such as an exclusive skin closure, plastic coverage such as a Bogotá bag, Wittmannpatch closure, or vacuum assisted closure (VAC®), being the latter the most used  (AU)</dc:description>
<dc:creator>Villagrán, M. J</dc:creator>
<dc:creator>Salgado, A</dc:creator>
<dc:creator>López, M</dc:creator>
<dc:creator>Gilsanz Rodríguez, Fernando</dc:creator>
<dc:creator>Gabilondo, G. A</dc:creator>
<dc:creator>Ramírez, A. S</dc:creator>
<dc:creator>Shiraldi, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Tratamiento: La descompresión quirúrgica vía laparotomía ha sido el tratamiento definitivo durante mucho tiempo; la indicación para un tratamiento quirúrgico (TQ) es el fallo del tratamiento médico (TM). Los pilares del TM se basan en mejorar la distensibilidad de la pared abdominal, evacuación de lesiones ocupantes de espacio intraabdominal, disminución de contenido intraluminal y optimización de la perfusión tisular. En estudios con animales se han empleado nuevos fármacos específicos como la melatonina y el octreótido con buenos resultados, pero aún no se han utilizado en humanos. El TQ consiste en la descompresión mediante laparotomía, manteniendo abierta la pared abdominal hasta mejorar los valores de la PIA y la presión de perfusión abdominal. El abdomen abierto debe ser protegido mediante un cierre abdominal temporal. Para realizarlo se han descrito diversas técnicas: cierre exclusivo de la piel, cobertura plástica tipo bolsa de Bogotá, cierre tipo Wittmannpatch y cierre con vacuum pack (VAC®), siendo este último el método más fisiológico; por esta razón algunos grupos lo consideran el tratamiento de elección (AU)</dc:description>
<dc:source>Actual. anestesiol. reanim;23(2): 8-16[2], abr.-jun. 2013. tab, ilus</dc:source>
<dc:identifier>ibc-114207</dc:identifier>
<dc:title xml:lang="es">Hipertensión intraabdominal y síndrome compartimental</dc:title>
<dc:subject>^d54490^s22036</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d54490^s22016</dc:subject>
<dc:subject>^d28418</dc:subject>
<dc:subject>^d3192^s22032</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3192^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d54490^s22032</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d54490^s22057</dc:subject>
<dc:subject>^d54490^s22012</dc:subject>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d3192^s22057</dc:subject>
<dc:subject>^d3192^s22016</dc:subject>
<dc:type>article</dc:type>
<dc:date>201306</dc:date>
</metadata>
</record>
</ibecs-document>
